The Latest Breaking News from AstraZeneca

Every 30 seconds, someone in the world will experience a flare-up of their asthma or chronic obstructive pulmonary disease (COPD) symptoms. For decades, the standard treatment for these potentially life-threatening episodes has remained unchanged – treatment with steroids, such as prednisolone.

Here's why Eli Lilly, Pfizer, and AstraZeneca are biotech stocks worth considering, with strong pipelines and growth potential beyond vaccines.

Choice of vaccine critic knocks some of world’s biggest drugmakers including Moderna, AstraZeneca and GSK

Profits beat forecasts but a 17% fall in share price since executives were detained by Beijing may be hard to shake

AstraZeneca beat third-quarter expectations and lifted its guidance Tuesday, and AstraZeneca stock rose despite a criminal probe in China.

UK’s biggest pharmaceutical company ‘committed to China’ as it raises 2024 profit forecast and announces $3.5bn US investment

The group’s shares have tumbled after it emerged that the firm’s China president has been detained as Chinese authorities deepen their investigation.

Cracks are appearing in the labour market after the unemployment rate today rose to 4.3%.

Leon Wang, president of AstraZeneca China, "has been detained", a representative of the firm's global media team said in an email to AFP.